ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Anuh Pharma disclosed a Rs. 9,93,206 tax demand under Section 156, Income Tax Act, for AY 2018-19. The company plans to appeal before the CIT.
Anuh Pharma reported strong Q1 FY27 results with 4% YoY revenue growth and 38% PAT growth, driven by a shift to high-value regulated markets.
Anuh Pharma announced the re-appointment of directors Arun Lalchand Todarwal and Bipin N. Shah, and the appointment of Ankit Kishor Chande as Cost Auditor.
Anuh Pharma Ltd held its 66th Annual General Meeting on August 12, 2026. The meeting covered the adoption of financial statements, dividend declaration, and director appointments.
Anuh Pharma Ltd. promoters withdrew their application for reclassification from 'Promoter Group' to 'Public' category. They will continue to remain part of the Promoter Group.
Anuh Pharma Ltd reported revenue from operations of ₹193.8 Cr (+3.9% YoY) and net profit of ₹11.4 Cr (+37.3% YoY) for Q1 FY27.
Anuh Pharma Ltd has scheduled a board meeting for August 7, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.
Anuh Pharma Ltd notified the exchange about dispatching physical letters to shareholders regarding the 66th Annual General Meeting and the availability of the FY 2025-26 Annual Report.
Anuh Pharma Ltd has submitted its 66th Annual Report for the financial year 2025-26. The report is now available for shareholders on the company's official website.
Anuh Pharma Ltd. has issued the notice for its 66th Annual General Meeting, scheduled for August 12, 2026, to conduct routine and special business.